164 related articles for article (PubMed ID: 33029537)
1. Oral Immunotherapy Using Probiotic Ice Cream Containing Recombinant Food-Grade
Vasiee A; Falah F; Sankian M; Tabatabaei-Yazdi F; Mortazavi SA
J Immunol Res; 2020; 2020():2635230. PubMed ID: 33029537
[TBL] [Abstract][Full Text] [Related]
2. Sublingual Immunotherapy with Sal k1 Expressing Lactococcus lactis Down-regulates Th2 Immune Responses in Balb/c Mice.
Ghasemi Z; Varasteh AR; Moghadam M; Jalali SA; Anissian A; Sankian M
Iran J Allergy Asthma Immunol; 2018 Jun; 17(3):281-290. PubMed ID: 29908546
[TBL] [Abstract][Full Text] [Related]
3. Lactococcus lactis harbouring Ara h 2.02 alleviates allergen-specific Th2-associated responses in sensitized mice.
Chan CJ; Yong YS; Song AAL; Abdul Rahim R; In LLA; Lim RLH
J Appl Microbiol; 2020 Mar; 128(3):862-874. PubMed ID: 31758869
[TBL] [Abstract][Full Text] [Related]
4. Production of Recombinant Protein of Salsola Kali (Sal k1) Pollen Allergen in Lactococcus Lactis.
Ghasemi Z; Varasteh AR; Moghadam M; Sedghi F; Jabbariazad F; Sankian M
Iran J Allergy Asthma Immunol; 2018 Apr; 17(2):134-143. PubMed ID: 29757586
[TBL] [Abstract][Full Text] [Related]
5. Nisin-induced expression of recombinant T cell epitopes of major Japanese cedar pollen allergens in Lactococcus lactis.
Van Hoang V; Ochi T; Kurata K; Arita Y; Ogasahara Y; Enomoto K
Appl Microbiol Biotechnol; 2018 Jan; 102(1):261-268. PubMed ID: 29094185
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy with a recombinant hybrid molecule alleviates allergic responses more efficiently than an allergenic cocktail or pollen extract in a model of chenopodium album allergy.
Nouri HR; Sankian M; Afsharzadeh D; Varasteh A
Int Arch Allergy Immunol; 2013; 161(4):325-32. PubMed ID: 23689669
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
Rossi RE; Monasterolo G
Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
[TBL] [Abstract][Full Text] [Related]
8. Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1.
Daniel C; Repa A; Wild C; Pollak A; Pot B; Breiteneder H; Wiedermann U; Mercenier A
Allergy; 2006 Jul; 61(7):812-9. PubMed ID: 16792578
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with recombinant molecules for allergy vaccination.
Cromwell O; Niederberger V; Horak F; Fiebig H
Curr Top Microbiol Immunol; 2011; 352():27-42. PubMed ID: 21562972
[TBL] [Abstract][Full Text] [Related]
10. Design and evaluation of a hypoallergenic peptide-based vaccine for Salsola kali allergy.
Tabesh S; Fanuel S; Fazlollahi MR; Yekaninejad MS; Kardar GA; Razavi SA
Int Immunopharmacol; 2019 Jan; 66():62-68. PubMed ID: 30445308
[TBL] [Abstract][Full Text] [Related]
11. Mucosal delivery of allergen peptides expressed by Lactococcus lactis inhibit allergic responses in a BALB/c mouse model.
Ai C; Zhang Q; Ding J; Wang G; Liu X; Tian F; Zhao J; Zhang H; Chen W
Appl Microbiol Biotechnol; 2016 Feb; 100(4):1915-1924. PubMed ID: 26621801
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of recombinant Lactococcus lactis expressing bovine beta-lactoglobulin partially prevents mice from sensitization.
Adel-Patient K; Ah-Leung S; Creminon C; Nouaille S; Chatel JM; Langella P; Wal JM
Clin Exp Allergy; 2005 Apr; 35(4):539-46. PubMed ID: 15836765
[TBL] [Abstract][Full Text] [Related]
13. Identification of polcalcin as a novel allergen of Amaranthus retroflexus pollen.
Vakili Moghaddam M; Fallahpour M; Mohammadi M; Rasi Varaee FS; Mokhtarian K; Khoshmirsafa M; Jafari R; Shirzad N; Falak R
Allergol Immunopathol (Madr); 2019; 47(4):357-364. PubMed ID: 30770138
[TBL] [Abstract][Full Text] [Related]
14. T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies.
Vrtala S; Akdis CA; Budak F; Akdis M; Blaser K; Kraft D; Valenta R
J Immunol; 2000 Dec; 165(11):6653-9. PubMed ID: 11086111
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.
Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ
J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262
[TBL] [Abstract][Full Text] [Related]
16. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
[TBL] [Abstract][Full Text] [Related]
17. Characterization of oral immune cells in birch pollen-allergic patients: impact of the oral allergy syndrome and sublingual allergen immunotherapy on antigen-presenting cells.
Mascarell L; Rak S; Worm M; Melac M; Soulie S; Lescaille G; Lemoine F; Jospin F; Paul S; Caplier L; Hasséus B; Björhn C; Zeldin RK; Baron-Bodo V; Moingeon P
Allergy; 2015 Apr; 70(4):408-19. PubMed ID: 25631199
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of allergen extracts from mugwort pollen desensitizes specific allergen-induced allergy in mice.
Ma WJ; Bao MJ; Zhu JP; Yao HY; Xie YC; Guan Y; Li FF; Dong XW; Zheng YM; Xie QM
Vaccine; 2012 Feb; 30(8):1437-44. PubMed ID: 22240342
[TBL] [Abstract][Full Text] [Related]
19. Epicutaneous immunotherapy with a hypoallergenic Bet v 1 suppresses allergic asthma in a murine model.
Siebeneicher S; Reuter S; Wangorsch A; Krause M; Foetisch K; Heinz A; Naito S; Reuter A; Taube C; Vieths S; Scheurer S; Toda M
Allergy; 2015 Dec; 70(12):1559-68. PubMed ID: 26304061
[TBL] [Abstract][Full Text] [Related]
20. Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: A randomized controlled trial.
Chaker AM; Shamji MH; Dumitru FA; Calderon MA; Scadding GW; Makatsori M; Jones I; He QA; Subramanian KK; Arm JP; Durham SR; Schmidt-Weber CB
J Allergy Clin Immunol; 2016 Feb; 137(2):452-461.e9. PubMed ID: 26531865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
